Optimizing VNS Parameters: Keys to Therapeutic Success
5 mins; July 08, 2025
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
4 mins; July 08, 2025
VNS: Beyond Seizure Control
5 mins; July 08, 2025
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
59 mins; July 07, 2025
New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
53 mins; July 02, 2025
PH Management in Unique Patients and Conditions
42 mins; July 02, 2025
Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
50 mins; July 02, 2025
Expert Perspectives on Nonsteroidal MRAs and Cardiorenal Protection
33 mins; June 19, 2025
Integrating IV Iron into Cancer Care: An Expert Overview of Best Practices
22 mins; June 10, 2025
Raising the Bar on Obesity Management in Psoriasis and Psoriatic Arthritis: A Collaborative Learning Experience for Dermatology and Rheumatology Healthcare Professionals
0 secs; June 10, 2025
Taking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
0 secs; June 10, 2025
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
52 mins; June 10, 2025
Bridging ASCVD Care Between Academic and Rural Settings
5 mins; June 09, 2025
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
5 mins; June 09, 2025
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
4 mins; June 09, 2025
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
13 mins; June 09, 2025
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
5 mins; June 09, 2025
Statins and Safety: What the Data Say About Dementia, Cancer, and More
7 mins; June 09, 2025
Target in Sight: Escalating Therapy to Reach LDL-C Goals
5 mins; June 09, 2025
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
2 mins; June 09, 2025
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
5 mins; June 09, 2025
When and Why to Use CAC Scoring
4 mins; June 09, 2025
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
7 mins; June 09, 2025
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
17 mins; June 08, 2025
Albuminuria Change and Finerenone's Effect on CV Outcomes
3 mins; June 06, 2025
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
3 mins; June 06, 2025
Topline Results of the CONFIDENCE Trial
4 mins; June 06, 2025
The CONFIDENCE Trial: Data Insights
3 mins; June 06, 2025
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
15 mins; June 05, 2025
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
8 mins; June 05, 2025
FSGS in Practice: Patient-Centered Decision-Making
19 mins; June 01, 2025
APOC3 Inhibition: A Novel Approach to Lowering TGs
4 mins; May 29, 2025
Beyond the Scale: How to Tackle Obesity’s Comorbidities
4 mins; May 29, 2025
FCS: Enhancing the Diagnosis
3 mins; May 29, 2025
Latest Clinical Trial Outcomes and Breakthroughs for FCS
3 mins; May 29, 2025
Obesity and Comorbidities: Strategies for Effective Patient Management
5 mins; May 29, 2025
Obesity: Unmasking the Chronic Disease Beneath the Weight
7 mins; May 29, 2025
Practical Tips for GLP-1 RA Therapy Success
5 mins; May 29, 2025
Remnant Cholesterol: The Missing Link in ASCVD risk
3 mins; May 29, 2025
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
3 mins; May 29, 2025
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
16 mins; May 29, 2025
SHTG: Decoding the Latest Clinical Trial Outcomes
5 mins; May 29, 2025
SHTG: Defining the Unmet Clinical Need
5 mins; May 29, 2025
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
4 mins; May 29, 2025
The Road Ahead: What's on the Horizon for FCS and SHTG Management
4 mins; May 29, 2025
Treating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery Treating Obesity: Lifelong Strategies fFrom Lifestyle to Pharmacotherapy and Surgery
5 mins; May 29, 2025
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
16 mins; May 22, 2025
Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
44 mins; May 08, 2025
Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
46 mins; May 08, 2025
New Frontiers in the Treatment of DMD Across the Age Spectrum
36 mins; May 08, 2025
First Results From Cohort 4 of the SunRISe-1 Trial
2 mins; April 30, 2025
Trial in Progress: Phase 3 MoonRISe-3 Study
2 mins; April 30, 2025
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
6 mins; April 29, 2025
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
7 mins; April 29, 2025
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
6 mins; April 29, 2025
Integrating New Therapies Into Healthcare
7 mins; April 29, 2025
Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
7 mins; April 29, 2025
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
4 mins; April 29, 2025
The Impact of Hemophilia Across Patients’ Lives
6 mins; April 29, 2025
The Promise and Future of Gene Therapy
5 mins; April 29, 2025
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
40 mins; April 29, 2025
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
29 mins; April 24, 2025
Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
15 mins; April 17, 2025
Chairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma
